Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease.
Alzheimer's disease
Cognition
Episodic memory
KL-VS
Klotho
Preclinical
amyloid-β
Journal
Neurobiology of aging
ISSN: 1558-1497
Titre abrégé: Neurobiol Aging
Pays: United States
ID NLM: 8100437
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
25
07
2018
revised:
04
12
2018
accepted:
27
12
2018
pubmed:
5
2
2019
medline:
18
12
2019
entrez:
5
2
2019
Statut:
ppublish
Résumé
The longevity gene Klotho (KL), specifically the functional KL-VS variant, has previously been associated with cognition and rates of cognitive decline. This study aimed to determine whether KL-VS associations with cognition were observable in preclinical Alzheimer's disease (AD). The study also aimed to determine whether there was a combined influence of KL-VS, neocortical amyloid-β (Aβ) burden, and carriage of the apolipoprotein E (APOE) ε4 allele on cognitive decline. This study involved 581 Aβ-imaged, cognitively normal older adults, enrolled in the Australian Imaging, Biomarkers and Lifestyle Study of Aging. Linear mixed effects models revealed no significant associations between KL-VS and cognitive decline independently or in combination with Aβ burden and APOE ε4 genotype. Overall, previous associations reported between KL-VS and cognitive decline are not observed at the preclinical stages of AD. Furthermore, the results do not support the hypothesis that KL-VS has a modifying effect on Aβ burden and APOE ε4-driven cognitive decline in preclinical AD.
Identifiants
pubmed: 30716541
pii: S0197-4580(18)30454-8
doi: 10.1016/j.neurobiolaging.2018.12.014
pii:
doi:
Substances chimiques
Amyloid beta-Peptides
0
Apolipoprotein E4
0
Glucuronidase
EC 3.2.1.31
Klotho Proteins
EC 3.2.1.31
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
162-165Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.